Literature DB >> 7067581

When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment.

A Sonnenberg, G Lepsien, S A Müller-Lissner, H R Koelz, J R Siewert, A L Blum.   

Abstract

In order to assess whether in reflux esophagitis morphological and functional disorders persist after macroscopic healing, cimetidine was given for 6-12 weeks at a dose of 1.6 g/day to 30 patients with acid gastroesophageal reflux and esophagitis. The mucosal defects healed in 6 patients, improved in 14 patients, and remained unchanged in 10 patients. Lower esophageal sphincter pressure, acid clearance, acid perfusion test, and histological signs of mucosal inflammation were assessed before and after treatment. The histological and functional findings did not improve after healing of the mucosal defects. Therefore, endoscopic normalization in patients with reflux esophagitis is not associated with the disappearance of inflammation and abnormal motor function. The persistence of these abnormalities might explain the tendency of esophagitis to recur after symptomatic and endoscopic "healing."

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067581     DOI: 10.1007/bf01296747

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  [The Göttingen pH measurement technic. Telemetric, long-term pH measurement of the esophagus].

Authors:  R Siewert; G Lepsien; G Schattenmann; A L Blum
Journal:  Chirurg       Date:  1978-05       Impact factor: 0.955

2.  Esophageal histology in gastroesophageal reflux. Morphometric findings in suction biopsies.

Authors:  U Seefeld; G J Krejs; R E Siebenmann; A L Blum
Journal:  Am J Dig Dis       Date:  1977-11

3.  Duodeno-gastric reflux and acid secretion in patients with symptomatic hiatal hermia.

Authors:  D W Stol; G M Murphy; J L Collis
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

4.  The pattern of bile salt reflux and acid secretion in sliding hiatal hernia.

Authors:  M K Crumplin; D W Stol; G M Murphy; J L Collis
Journal:  Br J Surg       Date:  1974-08       Impact factor: 6.939

5.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

6.  [Is axial hiatus hernia a disease entity].

Authors:  A L Blum; J R Siewert
Journal:  Schweiz Med Wochenschr       Date:  1979-12-29

7.  A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.

Authors:  R W McCallum; A F Ippoliti; C Cooney; R A Sturdevant
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

8.  [Endoscopic diagnosis of oesophagitis: problems of differentiation from normal (author's transl)].

Authors:  A Schüle; H Brändli; S Pelloni; H R Koelz; W J Pirozynski; A L Blum
Journal:  Dtsch Med Wochenschr       Date:  1977-04-22       Impact factor: 0.628

9.  [Are loss of glistening of normal colour and increased friability normal aspects of the oesophagus in old age? (author's transl)].

Authors:  H Leu; A Schüle; H Brändli; S Pelloni; L Blum
Journal:  Z Gastroenterol       Date:  1978-07       Impact factor: 2.000

10.  Experimental esophagitis in cats impairs lower esophageal sphincter pressure.

Authors:  G L Eastwood; D O Castell; R H Higgs
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

View more
  14 in total

1.  The use of cimetidine in hospitalized patients.

Authors:  L Kopala
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

2.  24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.

Authors:  D A Lieberman
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

Review 3.  Minimal changes in reflux esophagitis: red ones and white ones.

Authors:  Michio Hongo
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

4.  Oesophageal function before, during, and after healing of erosive oesophagitis.

Authors:  F Baldi; F Ferrarini; A Longanesi; M Angeloni; M Ragazzini; M Miglioli; L Barbara
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis.

Authors:  I C Wesdorp; W Dekker; H P Festen
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

6.  Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.

Authors:  F Pace; O Sangaletti; G Bianchi Porro
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

7.  Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood.

Authors:  S Cucchiara; R Minella; A Campanozzi; G Salvia; O Borrelli; E Ciccimarra; M Emiliano
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

8.  Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; G Romaniello; S Capobianco; S Auricchio
Journal:  Arch Dis Child       Date:  1984-09       Impact factor: 3.791

9.  Properly conducted fundoplication reverses histologic evidence of esophagitis.

Authors:  J D Richardson; J G Kuhns; R L Richardson; H C Polk
Journal:  Ann Surg       Date:  1983-06       Impact factor: 12.969

10.  Cimetidine therapy for gastroesophageal reflux disease.

Authors:  A P Archambault; A Farley; I G Cleator; N B Hershfield; H Navert; E J Prokipchuk; A B Thomson
Journal:  West J Med       Date:  1985-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.